Wenjie Lu
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid 7
- Pharmacology top 10%
-
- Pancreatic and Hepatic Oncology Research 6
-
- Inflammasome and immune disorders 4
-
- Pancreatitis Pathology and Treatment 3
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 2
-
- Autophagy in Disease and Therapy 3
-
- Renal cell carcinoma treatment 2
-
- Metabolism and Genetic Disorders 2
- Journals
- Journal of Neuroscience (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Wenjie Lu
34 papers receiving 683 citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Nephrology 211
- Biological Psychiatry 17
- Pharmacology 53
- Pathology and Forensic Medicine 108
- Cancer Research 90
Countries citing papers authored by Wenjie Lu
This map shows the geographic impact of Wenjie Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjie Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjie Lu more than expected).
Fields of papers citing papers by Wenjie Lu
This network shows the impact of papers produced by Wenjie Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjie Lu. The network helps show where Wenjie Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenjie Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 5 | |
| 14 | 2018 | 12 | |
| 15 | 2018 | 7 | |
| 16 | 2017 | 10 | |
| 17 | 2015 | 69 | |
| 18 | 2015 | 5 | |
| 19 | 2013 | 25 | |
| 20 | 2012 | 2 |
About Wenjie Lu
Wenjie Lu is a scholar working on Nephrology, Oncology and Clinical Biochemistry, having authored 39 papers that have together received 692 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Inflammasome and immune disorders (4 papers), Pancreatitis Pathology and Treatment (3 papers), Autophagy in Disease and Therapy (3 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers), Renal cell carcinoma treatment (2 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Nephrology (211 citations), Biological Psychiatry (17 citations) and Pharmacology (53 citations). Wenjie Lu has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Youzhi Xu, Hongquan Wei, Xiaojuan Yu, Hu Xu, Wen‐Tong Chen, Jie Jiang, Qianqian Sun, Yinglan Zhao, Fabao Gao and Xiaobo Cen. Their work appears in journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.